Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Active, not recruitingPhase 2 活肺通片治疗COPD稳定期的随机、双盲、安慰剂平行对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical trial of Huofeitong Tablets in the treatment of stable COPD
以安慰剂为对照,初步评价不同剂量活肺通片治疗COPD稳定期(肺肾两虚证)的有效性与安全性。
[Translation] Using placebo as control, the efficacy and safety of different doses of Huofeitong tablets in the treatment of stable COPD (lung and kidney deficiency syndrome) were preliminarily evaluated.
100 Clinical Results associated with Heyuan Jinyuan Green Life Co., Ltd.
0 Patents (Medical) associated with Heyuan Jinyuan Green Life Co., Ltd.
100 Deals associated with Heyuan Jinyuan Green Life Co., Ltd.
100 Translational Medicine associated with Heyuan Jinyuan Green Life Co., Ltd.